Published in Women's Health Weekly, August 23rd, 2007
"Our simulations showed that both I-PR and I-DR are effective to account for heterogeneous population sizes. The tests based on I-PR and I-DR are applied to a set of log-rate models for early-stage and late-stage breast cancer with socioeconomic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.